NCT06975774View on ClinicalTrials.gov

Phase II Clinical Clical of the Pure Protein Derivatives of BCG

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

January 15, 2024

Conditions
Tuberculosis
Interventions
DRUG

Purified Protein Derivative of BCG（BCG-PPD）

Thirty subjects were randomized, double-blinded to perform a homogeneous double-arm BCG-PPD skin test.

Trial Locations (1)

Unknown

The Third People's Hospital Of Shenzhen, Shenzhen

All Listed Sponsors
collaborator

Shenzhen Third People's Hospital

OTHER

lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY